Lansoprazole 30 mg Capsule (Lansoprazole Granule)

Adult dose

This medicine should be taken before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. To ensure the entire dose is taken, rinse the glass with twice that amount or more of juice and drink immediately. Do not chew or crush the medicine after opening the capsule. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence 1) Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if necessary. 2) Administer lansoprazole 30 mg with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. Comparative clinical trials did not exceed 12 months. Treatment of NSAID-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Comparative clinical trials did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. Comparative clinical trials did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome Lansoprazole dosing for pathological hypersecretory conditions varies by individual patient. Treatment in adults is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg per administration have been given twice daily. If more than 120 mg is administered per day, the dose should be divided. Because clearance of this medicine is reduced in elderly patients, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. In patients with hepatic impairment, metabolism and excretion of this medicine may be delayed; administer cautiously, including with dose adjustment.

Child dose

Children and adolescents aged 12 ∼ 17 years: Short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease — 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years: Short-term treatment of erosive reflux esophagitis — 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less — 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg — 30 mg once daily for 12 weeks

This drug should not be used in patients with known allergy to any of its ingredients or to benzimidazole derivatives. It should also be used with caution in patients allergic to penicillin or macrolide antibiotics when combined with this drug. It should not be administered to pregnant women or individuals with genetic issues like lactose intolerance. Use with caution in those with poor liver function, elderly patients, nursing mothers, and children, and observe for adverse reactions closely. Severe allergic reactions, blood abnormalities, liver function impairment, skin rashes, and other serious symptoms may occur during treatment; consult a physician immediately if any unusual symptoms arise. Regular monitoring is needed to check for nutritional status changes like vitamin B12 deficiency or hypomagnesemia during long-term use. Since this drug inhibits gastric acid secretion, there may be a slightly increased risk of gastrointestinal bacterial infections; inform healthcare professionals if symptoms like diarrhea persist. Furthermore, this drug may interact with other medications, and it is essential to inform healthcare personnel of any concomitant medications, particularly some antiviral drugs or antibiotics. It is safest to avoid using this drug during pregnancy or breastfeeding, and if necessary, a decision should be made after consultation with experts. Dizziness or drowsiness may occur; caution is advised when driving or operating machinery. Adhering strictly to minimum doses and duration as directed by a physician is critical during treatment, and seek immediate medical attention in case of overdose. Finally, store this medicine out of reach of children, and do not transfer it to another container.

Anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, urticaria, generalized rash, facial swelling, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, granulocytopenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute renal failure, membranous colitis, abdominal pain, frequent diarrhea, headache, diarrhea, abdominal distension, allergic reaction, back pain, weakness, candidiasis, carcinoma, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, malaise, neck stiffness, pelvic pain, angina pectoris, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased coughing, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory tract infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, acne, hair loss, pruritus, rash, contact dermatitis, dry skin, nail disease, skin cancer, skin disease, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eye, ear disease, eye disease, glaucoma, altered olfaction, photophobia, retinal degeneration, taste loss, blurred vision, deafness, eye pain, otitis media, taste distortion, tinnitus, visual narrowing, urination disorder, kidney pain, penile disease, testicular disease, urethral pain, polyuria, urgency, urinary retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, kidney stones, abdominal pain, vomiting, pancreatitis, taste disturbance, aplastic anemia, leukopenia, thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fracture, myositis, erythema multiforme, acute generalized exanthematous pustulosis, speech disorder, urinary hesitancy, increased AST, increased ALP, increased LDH, increased γ-GTP, fatigue, hyponatremia, elevated total cholesterol, decreased total cholesterol, paralysis of the tongue and lips, limb paralysis, constipation, dizziness, abdominal pain, stool abnormality, abdominal bloating, stomatitis, glossitis, thirst, heartburn, gastroesophageal reflux, loss of appetite, neutropenia, eosinophilia, leukocytosis, thrombocytopenia, rash, pruritus, drowsiness, insomnia, paralysis, depressive state, elevated triglycerides, elevated uric acid, positive urinary protein, positive urinary glucose, malaise, dizziness, visual impairment, drowsiness

Store this medication in a tightly sealed container to protect it from air and moisture. It is recommended to keep it at room temperature between 1 to 30 degrees Celsius.

Appearance

White to light brown granules in a hard capsule with a white upper part and a lower part.

Package unit

28 capsules/bottle